[Application and technique of breast conservative treatment of breast cancer]. 1992

S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
Department of Surgery, Tokyo Women's Medical College Daini Hospital, Japan.

In patients with breast cancer who had undergone breast conservative treatment involving lumpectomy, axillary lymph node dissection and irradiation, the surgical results and risk factors for remaining cancer foci in the conserved breast were investigated. This form of surgery was performed in 25 patients with T1,N0,-Ia,M0 breast cancer. The cut end of the resected specimen was histopathologically positive for cancer cells in 48% of the patients, but there has been no local or distant recurrence in any patient to date with a mean follow-up period of 17.2 months after surgery. In most breasts resected after lumpectomy, slight cancer foci remained in mammary glands at the sites within 1.0cm distant from the cut end. Extensive remaining cancer lesions were found among cases with advanced intraductal spread or central necrosis in the intraductal foci. The above findings indicate that breast conservative treatment by lumpectomy may result in histopathologically remaining cancer foci, although these can be controlled by irradiation therapy. However, application for this treatment requires much caution when severe intraductal spread or central necrosis is present in the intraductal foci, because extensive cancer foci may remain postoperatively in such cases.

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
October 1985, World journal of surgery,
S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
November 1994, Ginekologia polska,
S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
January 1983, Revista paulista de medicina,
S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
April 1985, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
March 1978, La Revue du praticien,
S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
January 1983, Revista chilena de obstetricia y ginecologia,
S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
May 1988, Meditsinskaia radiologiia,
S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
January 1963, Arquivos de oncologia,
S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
June 2002, Archives of surgery (Chicago, Ill. : 1960),
S Haga, and T Shimizu, and J Kinoshita, and K Kobayashi, and O Watanabe, and T Kajiwara, and T Okawa
May 2002, Radiologic clinics of North America,
Copied contents to your clipboard!